Open-house rebate agreement for Tiaprid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 462 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiaprid, ATC N05AL03

62/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

The notice explicitly says the contract documents must be submitted via the communication area in the DTVP portal and n...

Only pharmaceutical companies are eligible as potential contract partners, and a signed declaration of reliability is r...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Jan 2028
Non-exclusive open-house rebate agreements for the medicinal product Tiaprid, ATC N05AL03.
Supply contract for pharmaceutical products.

Show full summary

This is an open-house pharmaceutical supply arrangement for Tiaprid (ATC N05AL03) led by AOK Bayern. It is not a competitive open procedure in substance: the notice states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 2026-02-01 to 2028-01-31, with contract entry possible until 2027-12-03. Submission is via DTVP electronic channel with a qualified electronic signature, or by signed paper originals in duplicate. No contract value is stated.

Risks

The notice explicitly says the contract documents must be submitted via the communication area in the DTVP portal and n...

Only pharmaceutical companies are eligible as potential contract partners, and a signed declaration of reliability is r...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

Submit the signed contract, the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and the signed declaration of reliability.
The declaration of reliability must be signed and submitted with the tender documents.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Tiaprid

Open-house non-exclusive pharmaceutical rebate agreement for Tiaprid (ATC N05AL03). Scope is supply of pharmaceutical products under a pre-set contract; the notice says the contract terms are identical and not individually negotiable. Place of performance is Germany, region DE212 (Bavaria/Munich area as indicated by buyer address and lot data).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Procurement Details

Publication date: 14 Dec 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 831717-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3